Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;31(4):344-362.
doi: 10.1521/aeap.2019.31.4.344.

Association of Injection Practices and Overdose With Drug Use Typologies: A Latent Class Analysis Among People Who Inject Drugs in Baltimore, 2017

Affiliations

Association of Injection Practices and Overdose With Drug Use Typologies: A Latent Class Analysis Among People Who Inject Drugs in Baltimore, 2017

Rachel E Gicquelais et al. AIDS Educ Prev. 2019 Aug.

Abstract

Increasing overdose mortality and new HIV outbreaks in the U.S. highlight the need to identify risk behavior profiles among people who inject drugs (PWID). We characterized latent classes of drug use among a community-based sample of 671 PWID in Baltimore during 2017 and evaluated associations of these classes with sharing syringes, obtaining syringes from pharmacies or syringe services programs (SSPs), and nonfatal overdose in the past 6 months. We identified three classes of current drug use: infrequent use (76% of participants), prescription drug use (12%), and heroin and/or cocaine injection (12%). PWID in the heroin and/or cocaine injection and prescription drug use classes had higher odds of both overdose and sharing syringes (relative to infrequent use). PWID in the prescription drug use class were 64% less likely to obtain syringes through SSPs/pharmacies relative to heroin and/or cocaine injection. Harm reduction programs need to engage people who obtain prescription drugs illicitly.

Keywords: harm reduction; latent class analysis; overdose; people who inject drugs; syringe sharing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Latent Classes of Drug Use among Current and Former People who Inject Drugs in Baltimore, MD, 2017 We interpreted item response probabilities for a 3-class model of drug use to characterize the predominant drug use typologies among participants in the ALIVE study during 2017. Most participants (76.3%) were assigned to an infrequent drug use class. All participants in the infrequent use class used ≤5 total substances and tended to use
Figure 2
Figure 2
Associations of Drug Use Class with Overdose, Syringe Sharing, and Obtaining Syringes among 671 Current and Former People who Inject Drugs in Baltimore, MD, 2017 We examined how membership in the heroin and/or cocaine injection (top) and prescription drug use classes (middle) was associated with three outcomes relative to infrequent use: overdose, syringe sharing (among 431 participants who injected drugs in the past 6 months), and obtaining syringes from the Baltimore City Needle Exchange Program (BCNEP) or a pharmacy (among 431 participants who injected drugs in the past 6 months) using logistic regression. We also compared prescription drug use with heroin and/or cocaine injection (bottom). Adjusted results present the association of class with outcomes after adjustment for age, African American race, gender, homelessness, HIV (status and viral load detectability), depression, and alcohol use. Participants in the prescription drug use class had elevated odds of overdose and sharing syringes, but not of obtaining syringes compared to participants in the infrequent use class. Participants in the heroin and/or cocaine injection classes had higher odds of overdose, sharing syringes, and obtaining syringes relative to participants in the infrequent use class. Participants in the prescription drug use class were less likely to obtain syringes relative to participants in the heroin and/or cocaine injection class.

Similar articles

Cited by

References

    1. Anagnostopoulos A, Abraham AG, Genberg BL, Kirk GD, & Mehta SH (2018). Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore. Addictive Behaviors, 81, 39–45. 10.1016/j.addbeh.2018.01.024 - DOI - PMC - PubMed
    1. Bolck A, Croon M, & Hagenaars J (2004). Estimating Latent Structure Models with Categorical Variables: One-Step Versus Three-Step Estimators. Political Analysis, 12(1), 3–27.
    1. Boodram B, Hotton AL, Shekhtman L, Gutfraind A, & Dahari H (2018). High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 95(1), 71–82. 10.1007/s11524-017-0185-7 - DOI - PMC - PubMed
    1. Bruneau J, Roy E, Arruda N, Zang G, & Jutras-Aswad D (2012). The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction (Abingdon, England), 107(7), 1318–1327. 10.1111/j.1360-0443.2012.03803.x - DOI - PubMed
    1. CDC. (2011). HIV surveillance--United States, 1981–2008. MMWR. Morbidity and Mortality Weekly Report, 60(21), 689–693. - PubMed

Publication types

LinkOut - more resources